From: Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii
Group number | After challenge | |||
---|---|---|---|---|
Day post-challenge | Body weight | Clinical score | Survival rate (%) | |
pDNA- CPG C274/CSNP | Before challenge | 18.7 | 0 | 100 |
1 Day post-challenge | 17.5 | −1 | 100 | |
3 Day post-challenge | 15.8 | −2 | 100 | |
7 Day post-challenge | 18.1 | −1 | 75 | |
pDNA- CPG C274 | Before challenge | 18.2 | 0 | 100 |
1 Day post-challenge | 17.1 | −2 | 75 | |
3 Day post-challenge | 14.1 | −3 | 75 | |
7 Day post-challenge | 17.8 | −4 | 50 | |
Free- CPG C274 | Before challenge | 18.9 | 0 | 100 |
1 Day post-challenge | 17.9 | −2 | 75 | |
3 Day post-challenge | 14.8 | −3 | 75 | |
7 Day post-challenge | 18.2 | −5 | 25 | |
Free-pDNA/CSNP | Before challenge | 18.4 | 0 | 100 |
1 Day post-challenge | 17.8 | −5 | 0 | |
3 Day post-challenge | 15.1 | −5 | 0 | |
7 Day post-challenge | 18 | −5 | 0 | |
Free-pDNA | Before challenge | 18.3 | 0 | 100 |
1 Day post-challenge | 18.1 | −5 | 0 | |
3 Day post-challenge | 15.3 | −5 | 0 | |
7 Day post-challenge | 17.9 | −5 | 0 | |
CSNP | Before challenge | 18.6 | 0 | 100 |
1 Day post-challenge | 18.1 | −5 | 0 | |
3 Day post-challenge | 16.2 | −5 | 0 | |
7 Day post-challenge | 18.2 | −5 | 0 | |
PBS | Before challenge | 18.9 | 0 | 100 |
1 Day post-challenge | 18.0 | −5 | 0 | |
3 Day post-challenge | 16.1 | −5 | 0 | |
7 Day post-challenge | 18.3 | −5 | 0 |